相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。18F-FLT PET/CT imaging for early monitoring response to CDK4/6 inhibitor therapy in triple negative breast cancer
Guang Ma et al.
ANNALS OF NUCLEAR MEDICINE (2021)
Olaparib monotherapy as primary treatment in unselected triple negative breast cancer
H. P. Eikesdal et al.
ANNALS OF ONCOLOGY (2021)
[89Zr]-Pertuzumab PET Imaging Reveals Paclitaxel Treatment Efficacy Is Positively Correlated with HER2 Expression in Human Breast Cancer Xenograft Mouse Models
Yun Lu et al.
MOLECULES (2021)
A call for caution in analysing mammalian co-transfection experiments and implications of resource competition in data misinterpretation
Roberto Di Blasi et al.
NATURE COMMUNICATIONS (2021)
Visualization of the cancer cell cycle by tissue-clearing technology using the Fucci reporter system
Kei Takahashi et al.
CANCER SCIENCE (2021)
Design, Synthesis, and Evaluation of 11C-Labeled 3-Acetyl-Indole Derivatives as a Novel Positron Emission Tomography Imaging Agent for Diacylglycerol Kinase Gamma (DGKγ) in Brain
Yasushi Hattori et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial
Peter Schmid et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Anti-HER2 induced myeloid cell alterations correspond with increasing vascular maturation in a murine model of HER2+breast cancer
Meghan J. Bloom et al.
BMC CANCER (2020)
Optical Imaging Modalities: Principles and Applications in Preclinical Research and Clinical Settings
Giacomo Pirovano et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies
Antonio Marra et al.
NPJ BREAST CANCER (2020)
The use of 3′-deoxy-3′-18F-fluorothymidine (FLT) PET in the assessment of long-term survival in breast cancer patients treated with neoadjuvant chemotherapy
Benjamin E. Ueberroth et al.
ANNALS OF NUCLEAR MEDICINE (2019)
Cell-Proliferation Imaging for Monitoring Response to CDK4/6 Inhibition Combined with Endocrine-Therapy in Breast Cancer: Comparison of [18F]FLT and [18F]ISO-1 PET/CT
Azadeh Elmi et al.
CLINICAL CANCER RESEARCH (2019)
Associations Between PET Parameters and Expression of Ki-67 in Breast Cancer
Alexey Surov et al.
TRANSLATIONAL ONCOLOGY (2019)
Virtual histological staining of unlabelled tissue-autofluorescence images via deep learning
Yair Rivenson et al.
NATURE BIOMEDICAL ENGINEERING (2019)
Ki-67 protein as a tumour proliferation marker
Sunil Sankunny Menon et al.
CLINICA CHIMICA ACTA (2019)
Safety and Relative Dose Intensity of Dose-dense Doxorubicin and Cyclophosphamide Followed by Dose-dense Paclitaxel
Meiko Nishimura et al.
ANTICANCER RESEARCH (2019)
Advances in Targeted Therapies for Triple-Negative Breast Cancer
Kelly E. McCann et al.
DRUGS (2019)
Exploring Tumor Heterogeneity Using PET Imaging: The Big Picture
Clement Bailly et al.
CANCERS (2019)
Imaging of Endogenous Hydrogen Peroxide during the Process of Cell Mitosis and Mouse Brain Development with a Near-Infrared Ratiometric Fluorescent Probe
Hailong Guo et al.
ANALYTICAL CHEMISTRY (2019)
Intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for neoadjuvant treatment of high-risk early breast cancer (GeparOcto-GBG 84): A randomised phase III trial
Andreas Schneeweiss et al.
EUROPEAN JOURNAL OF CANCER (2019)
Molecular Imaging in Breast Cancer
Daniela Miladinova
NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Tumour heterogeneity and resistance to cancer therapies
Ibiayi Dagogo-Jack et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Ki-67: more than a proliferation marker
Xiaoming Sun et al.
CHROMOSOMA (2018)
Repeatability of quantitative 18F-FLT uptake measurements in solid tumors: an individual patient data multi-center meta-analysis
G. M. Kramer et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Emerging ways to treat breast cancer: will promises be met?
Pouria Samadi et al.
CELLULAR ONCOLOGY (2018)
Real-Time Determination of the Cell-Cycle Position of Individual Cells within Live Tumors Using FUCCI Cell-Cycle Imaging
Shuya Yano et al.
CELLS (2018)
Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamer
Simona Camorani et al.
THERANOSTICS (2018)
Intratumoral heterogeneity of 18F-FLT uptake predicts proliferation and survival in patients with newly diagnosed gliomas
Katsuya Mitamura et al.
ANNALS OF NUCLEAR MEDICINE (2017)
Cancer heterogeneity and imaging
James P. B. O'Connor
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2017)
Tumor size and proliferative marker geminin rather than Ki67 expression levels significantly associated with maximum uptake of 18F-deoxyglucose levels on positron emission tomography for breast cancers
Arisa Nishimukai et al.
PLOS ONE (2017)
Ki67, PCNA, and MCM proteins: Markers of proliferation in the diagnosis of breast cancer
Miroslava Jurikova et al.
ACTA HISTOCHEMICA (2016)
An unbiased metric of antiproliferative drug effect in vitro
Leonard A. Harris et al.
NATURE METHODS (2016)
FUCCI sensors: powerful new tools for analysis of cell proliferation
N. Zielke et al.
WILEY INTERDISCIPLINARY REVIEWS-DEVELOPMENTAL BIOLOGY (2015)
Ki67 is a promising molecular target in the diagnosis of cancer
Lian Tao Li et al.
MOLECULAR MEDICINE REPORTS (2015)
CTLs regulate tumor growth via cytostatic effects rather than cytotoxicity: a few T cells can influence the growth of many times more tumor cells
Kazuhiro Kakimi et al.
ONCOIMMUNOLOGY (2015)
FLT PET-CT in evaluation of treatment response
Bal Sanghera et al.
INDIAN JOURNAL OF NUCLEAR MEDICINE (2014)
Targeting cell cycle regulation in cancer therapy
Santiago Diaz-Moralli et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Transcriptional effects of transfection: the potential for misinterpretation of gene expression data generated from transiently transfected cells
Linda B. Jacobsen et al.
BIOTECHNIQUES (2009)
Visualizing spatiotemporal dynamics of multicellular cell-cycle progression
Asako Sakaue-Sawano et al.
CELL (2008)
Use of FDG-PET to monitor response to chemotherapy and radiotherapy in patients with lymphomas
N. George Mikhaeel
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
Targeting the cell cycle: A new approach to cancer therapy
GK Schwartz et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)